A rating of 76 puts Alterity Therapeutics Ltd (ATHE) near the top of the Biotechnology industry according to InvestorsObserver. Alterity Therapeutics Ltd's score of 76 means it scores higher than 76% of stocks in the industry. Alterity Therapeutics Ltd also received an overall rating of 61, putting it above 61% of all stocks. Biotechnology is ranked 34 out of the 148 industries.
What do These Ratings Mean?
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Alterity Therapeutics Ltd Stock Today?
Alterity Therapeutics Ltd (ATHE) stock is higher by 7.18% while the S&P 500 is down -2.2% as of 10:44 AM on Tuesday, Sep 8. ATHE has gained $0.14 from the previous closing price of $1.95 on volume of 65,314 shares. Over the past year the S&P 500 has risen 12.53% while ATHE has gained 97.17%. ATHE lost -$0.49 per share the over the last 12 months.
Click Here to get the full Stock Score Report on Alterity Therapeutics Ltd (ATHE) Stock.
